Go to industries

Healthcare

Critical guidance on your journey

With new and groundbreaking technology constantly challenging the status quo, the healthcare industry is progressing by leaps and bounds. But in an industry built on regulations, strategic partnerships are often the key to successfully developing businesses. Our passionate advisors, backed by sub-sector teams globally, use their deep expertise in M&A, growth equity and ECM, debt advisory and corporate finance services to find your competitive edge, navigate local customs and help you create the most suitable strategy.

Contact advisor
Worldwide
426
deals closed in Healthcare
Worldwide
Explore all our industry-related deals
Go to deals
Clínica Ricardo Palma has sold a 50% stake to Quirónsalud
Healthcare

Clínica Ricardo Palma has sold a 50% stake to Quirónsalud

The shareholders of Administradora Clínica Ricardo Palma S.A. (Clínica Ricardo Palma) have sold 50% of their shares to Quirónsalud for an undisclosed consideration.

Learn more
TDK Corporation has divested its medical business HTI Medical to GTCR-backed Resonetics
Private Equity | Healthcare

TDK Corporation has divested its medical business HTI Medical to GTCR-backed Resonetics

Hutchinson Technology, Inc., a subsidiary of TDK Corporation, has sold its medical business HTI Medical to Resonetics, a portfolio company of GTCR.

Learn more
Enterprises ImportFab Inc. has been acquired by Labomar S.p.A
Healthcare

Enterprises ImportFab Inc. has been acquired by Labomar S.p.A

Labomar S.p.A., a leading company in the research, development and production of food supplements, medical devices and foods for specific medical and cosmetic purposes, has acquired Enterprises ImportFab Inc., a Canadian firm based in Montréal that operates in the North American pharmaceutical, cosmetic and nutraceutical market. The operation has been carried out in partnership with SIMEST that will participate in the acquisition and will hold a minority share of the Canadian company.

Learn more
“I am very happy with the deal we closed and I don’t think I could have expected a better outcome. The company I have built will continue to grow and my employees are protected. The Oaklins team did an amazing job. Their professionalism and dedication were beyond my expectations. I would highly recommend them to anyone looking for a financial advisor you can trust.”

Sylvain Renzi

Founder, Enterprises ImportFab, Inc.

Read more
Example: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=AT&includes=featured_images,tags&language=de-AT&limit=3&tags=healthcare 
Ours: https://newsroom-api.pr.co/v1/pressrooms/oaklins/tagged/press_releases?country=PE&includes=featured_images,tags&language=en-PE&limit=1&tags=healthcare

High deal activity driven by digitalization and sustainability

MONTHLY DEAL ACTIVITY: In October 2021, we closed 27 transactions of which 20 were M&A deals and 7 were fundraising deals. We expect deal activity to continue the upward trajectory we have witnessed so far this year.

Learn more

Talk to our local advisors

 Eduardo  Campos

Eduardo Campos

Partner

Lima, Peru
Oaklins APOYO

Meet our global industry specialists

 Robert  Boersma

Robert Boersma

Partner

Amsterdam, Netherlands
Oaklins Netherlands
 Dino  Theodorou

Dino Theodorou

Director

Johannesburg, South Africa
Oaklins Grindrod
 Stuart  Goodman

Stuart Goodman

Director

London, United Kingdom
Oaklins Smith & Williamson
 Michael  Jewell

Michael Jewell

Partner

London, United Kingdom
Oaklins Cavendish
 Michael S. Goldman

Michael S. Goldman

Managing Director

New York, United States
Oaklins TM Capital